Ingenieur mit Schwerpunkt Automatisierung/Mess- und Regeltechnik

Your role Sie wirken bei der Fortentwicklung der Automatisierungsstrategien des Standortes vor allem zur Steuerung der zahlreichen Produktionsanlagen, die der Produktion von Pharmawirkstoffen dienen, mit Sie leiten eigenständig PLT/EMSR Projekte und sind verantwortlich für die fachliche Konzeption, die Umsetzung der Projekte, die Inbetriebnahme der Anlagen sowie die Kosten und Termineinhaltung. Sie verantworten außerdem das Qualitätsmanagement in den Projekten Sie wirken mit bei den Wartungs-, Inspektions- und Instandhaltungsmaßnahmen der Betriebe im Bereich der Automatisierung, Messtechnik, Elektro- und Prozessleittechnik Sie sind beteiligt an der Budgetplanung für PLT/EMSR Projekte und der PLT/EMSR-Instandhaltung Sie stellen die elektrische Energieversorgung (Mittel- und Niederspannung) am Standort sicher Your profile Abschluss als Ingenieur mit Fachrichtung Elektrotechnik oder vergleichbar Kenntnisse im Bereich Verfahrenstechnik wünschenswert Ausgeprägte Fähigkeit zum selbstständigen Arbeiten Kommunikations-und Teamfähigkeit Gute Deutsch-und Englischkenntnisse Bereits vorhandene Berufserfahrung ist von Vorteil Working at Siegfried Siegfried's work environment is dynamic and international. With a highly professional and motivated team, the company operates in a future-oriented business field. Siegfried possesses a unique culture that leverages cultural differences to create a competitive advantage. Siegfried places highest priority on providing a flexible, diverse and discrimination-free working environment in which employees can develop personally and professionally, advance innovation and deliver superior performance. We strive to provide a work environment where employees can take on challenging jobs and associated responsibilities that best serve their personal and technical development and can benefit from the success of our company. The company regulations in respect of compensation and career development opportunities apply to all Siegfried sites. Additional conditions of employment are governed by location-specific circumstances, legislation and customs. Who we are In the Midst of People’s Lives – Across the GlobeThe Siegfried Group is one of the world’s leading Custom Development and Manufacturing Organizations (CDMOs) developing and producing active pharmaceutical ingredients (API), intermediates and finished dosage forms. As our core competence, we successfully integrate chemical and pharmaceutical capabilities into a single business model. The Siegfried name stands for highest quality, efficiency, flexibility and safety. Present in Europe, Asia and North America, we serve a broad global customer base from major international pharmaceutical companies down to small biologic-pharmaceutical organizations. For them we develop and produce product innovations on a large scale to finished products. We integrate our offer seamlessly into the customers’ value chain. Our comprehensive services range from early-stage Research & Development services such as synthesis, scale-up, formulation development, stability studies and method development all the way through to manufacturing services, ranging from preclinical R&D material for clinical trial purposes to commercial production. We are able to produce about 200 of the approximately 1500 registered drug substances used in medicine. Moreover, we produce 20 percent of global demand for caffeine. Consequently, nearly 1 billion individuals come into contact with Siegfried products. What we do in Minden For the last 80 years, Siegfried PharmaChemikalien Minden GmbH has been producing active pharmaceutical ingredients (APIs) and the corresponding intermediates at its Minden facility, to meet worldwide demand from the pharmaceutical industry. We also produce ingredients for the cosmetics and food industries. Main activities Development and commercial manufacture of active pharmaceutical ingredients (APIs) and corresponding intermediates  Fully compliant with cGMP and SHE (Safety, Health and Environmental) standards Special features Handling of high potency substances in development and production Comprehensive handling of solids in production Production capacity: 1450 m³ Reactors: 0.2–30 m³ Handling of highly toxic substances in encapsulated plants Successful transfers of new products into commercial production Biotechnology implementations Strategic importance Contract manufacturing of new active ingredients